Detalhe da pesquisa
1.
Impact of clinicopathological features on immune-based combinations for advanced urothelial carcinoma: a meta-analysis.
Future Oncol
; 18(6): 739-748, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35048736
2.
Dual immune checkpoint blockade in hepatocellular carcinoma: where do we stand?
Future Oncol
; 18(8): 1023-1034, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-35109664
3.
Current and Future Role of Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: Which Way to Go Forward.
Medicina (Kaunas)
; 58(5)2022 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35630016
4.
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study.
Medicina (Kaunas)
; 58(11)2022 Oct 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36363500
5.
Metaplastic breast cancer: an old histotype but a current therapeutic problem.
Future Oncol
; 17(8): 955-963, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-33538176
6.
Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes.
Oncologist
; 21(11): 1298-1305, 2016 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-27742906
7.
The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1.
Future Oncol
; 12(3): 281-4, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26775918
8.
The calm before the storm: a report from the International Liver Cancer Association Congress 2015 - part 2.
Future Oncol
; 12(3): 285-8, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26776157
9.
Sorafenib: 10 years after the first pivotal trial.
Future Oncol
; 11(13): 1863-80, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26161924
10.
The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer.
Cancer Causes Control
; 25(11): 1531-41, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25135616
11.
EASL HCC summit: liver cancer management.
Future Oncol
; 10(7): 1129-32, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24947253
12.
Unresectable lung malignancy: combination therapy with segmental pulmonary arterial chemoembolization with drug-eluting microspheres and radiofrequency ablation in 17 patients.
Radiology
; 267(2): 627-37, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23249572
13.
The Mediterranean Lifestyle to Contrast Low-Grade Inflammation Behavior in Cancer.
Nutrients
; 15(7)2023 Mar 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37049508
14.
Safety evaluation of Datopotamab deruxtecan for triple-negative breast cancer: a meta-analysis.
Cancer Treat Res Commun
; 37: 100775, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37956525
15.
Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 10: 1445-1463, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37701562
16.
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis.
Cancers (Basel)
; 15(2)2023 Jan 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36672330
17.
Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma?
Expert Rev Gastroenterol Hepatol
; 16(4): 333-339, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35403533
18.
The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-Analysis.
J Pers Med
; 12(5)2022 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-35629263
19.
Lenvatinib plus pembrolizumab: the next frontier for the treatment of hepatocellular carcinoma?
Expert Opin Investig Drugs
; 31(4): 371-378, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34167433
20.
Immune-based combinations for metastatic triple negative breast cancer in clinical trials: current knowledge and therapeutic prospects.
Expert Opin Investig Drugs
; 31(6): 557-565, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-34802383